Carl Zeiss Meditec AG (ETR:AFX – Get Free Report) shares traded up 1.1% during trading on Tuesday . The company traded as high as €104.70 ($111.38) and last traded at €103.40 ($110.00). 81,691 shares changed hands during mid-day trading, a decline of 13% from the average session volume of 94,405 shares. The stock had previously closed at €102.30 ($108.83).
Carl Zeiss Meditec Stock Performance
The company has a debt-to-equity ratio of 7.16, a quick ratio of 2.47 and a current ratio of 3.40. The stock’s 50-day moving average is €113.29 and its 200 day moving average is €97.75. The firm has a market cap of $9.25 billion, a P/E ratio of 33.35, a PEG ratio of 3.86 and a beta of 0.92.
About Carl Zeiss Meditec
Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders.
Featured Articles
- Five stocks we like better than Carl Zeiss Meditec
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- Silicon Motion Proves That AI in Motion Stays in Motion
- Investing In Preferred Stock vs. Common Stock
- Undervalued UnitedHealth Group Won’t Be For Long
- What Investors Need to Know About Upcoming IPOs
- The 5 Stocks Most Sold By Insiders This Year
Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.
